”Lasten idiopaattisen varvaskävelyn botuliinihoito – satunnaistettu kontrolloitu arvioijasokkoutettu tutkimus”

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2009-017308-10-FI

Enrollment

Unknown

Registered

2009-11-25

Start date

2009-12-22

Completion date

Unknown

Last updated

2016-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic toe-walkers

Interventions

Trade Name: Botox Pharmaceutical Form: Trade Name: Botox Pharmaceutical Form: Injection*

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Verified idiopathic toewalking No achilles contracture Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: No surgery or casting or previous botulinum toxin injections

Design outcomes

Primary

Measure	Time frame
Main Objective: To compare fysiotherapy and fysiotherapy + botulinum toxin when treating idiopathic toewalking;Secondary Objective: ;Primary end point(s): Follow-up 2 years	—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026